2019. HIGH-DOSE-RATE BRACHYTHERAPY FOR PROSTATE CANCER: DIRECT IN VIVO DOSIMETRY IS AN IMPORTANT FACTOR IN INCREASING THE EFFECTIVENESS OF TREATMENT AND REDUCING THE INCIDENCE OF COMPLICATIONS. Voprosy onkologii. 65, 4 (Apr. 2019), 596–602. DOI:https://doi.org/10.37469/0507-3758-2019-65-4-596-602.